Retrieve Medical Holdings EBITDA Margin 2010-2024 | RMHI
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Retrieve Medical Holdings (RMHI) over the last 10 years. The current EBITDA margin for Retrieve Medical Holdings as of September 30, 2024 is .
| Retrieve Medical Holdings EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.085B | $0.000B |
| Retrieve Medical Inc. is a software company. It is commercializing a patented Clinical Documentation Improvement platform, Retrieve Dx(TM), which enhances physician ability to quickly understand the complex clinical history of patients and diagnose chronic conditions by analyzing physician notes, lab results, radiology reports, EKG interpretations and more. Retrieve Medical Inc., formerly known as Peak Pharmaceuticals Inc., is based in SCOTTSDALE, AZ. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $37.687B | 52.05 |
| Tempus AI (TEM) | United States | $9.349B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $7.785B | 125.14 |
| Inspire Medical Systems (INSP) | United States | $4.759B | 92.44 |
| IRhythm Technologies (IRTC) | United States | $3.404B | 0.00 |
| Privia Health (PRVA) | United States | $2.840B | 212.82 |
| Enovis (ENOV) | United States | $1.994B | 12.34 |
| Schrodinger (SDGR) | United States | $1.883B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.763B | 0.00 |
| Omnicell (OMCL) | United States | $1.471B | 31.72 |
| Phreesia (PHR) | United States | $1.461B | 0.00 |
| Azenta (AZTA) | United States | $1.216B | 56.62 |
| 10x Genomics (TXG) | United States | $1.025B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.583B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.560B | 0.00 |
| Talkspace (TALK) | United States | $0.532B | 316.00 |
| Veradigm (MDRX) | United States | $0.457B | 0.00 |
| Standard BioTools (LAB) | United States | $0.440B | 0.00 |
| TruBridge (TBRG) | United States | $0.389B | 0.00 |
| Claritev (CTEV) | United States | $0.373B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.286B | 0.00 |
| Pulmonx (LUNG) | United States | $0.212B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.211B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.204B | 0.00 |
| American Well (AMWL) | United States | $0.114B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.094B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.082B | 0.00 |
| CareCloud (CCLD) | United States | $0.077B | 3.31 |
| 111 (YI) | China | $0.072B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.063B | 0.00 |
| HeartBeam (BEAT) | United States | $0.061B | 0.00 |
| Outset Medical (OM) | United States | $0.041B | 0.00 |
| Zepp Health (ZEPP) | China | $0.040B | 0.00 |
| Zhongchao (ZCMD) | China | $0.028B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.017B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.016B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.014B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.013B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| Precipio (PRPO) | United States | $0.009B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.007B | 0.00 |
| Movano (MOVE) | United States | $0.006B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |